"Among the top 2% of the world's Bioengineers"

Dr. Klonoff has long been regarded as one the leaders in the field of diabetes technology.   In 2019, he was recognized with the American Diabetes Association’s Outstanding Physician Clinician Award.  He also received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. In 2012 Dr. Klonoff was elected as a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and cited as among the top 2% of the world’s bioengineers for his engineering work in diabetes technology.  His experience in the area of Diabetes and Technology is vast as he has chaired or served on 58 grant review panels including for NIH, CDC, NASA, NSF, US Army, NOAA, ADA, and JDRF; plus agencies in ten foreign countries.  He chaired the first and second CLSI POCT05 Performance Metrics for Continuous Interstitial Glucose Monitoring Panel, the Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital Consensus Guideline, and the Continuous Ketone Monitoring Panel. He has authored over 270 publications in PubMed journals including four of the first ten articles on diabetes device cybersecurity, is Chair of the IEEE 2621 Standards for Wireless Diabetes Device Security Assurance Committee, and he chaired DTSec and DTMoSt — the world’s first and second consensus medical device cybersecurity standards. He has been a Principal Investigator in over 120 clinical trials of diabetes drugs and devices.